Literature DB >> 15137994

Determination of celecoxib in human plasma by high-performance liquid chromatography.

Hassan Jalalizadeh1, Mohsen Amini, Vahid Ziaee, Ali Safa, Hassan Farsam, Abbas Shafiee.   

Abstract

A high performance liquid chromatographic method for the quantitation of celecoxib (CEL) in human plasma is presented. The method is based on liquid-liquid extraction with chloroform and reversed-phase chromatography using a Nucleosil CN column (250 mm x 4.6 mm i.d., 5 microm particle size) and UV spectrophotometer detection at 260 nm. The mobile phase consists of acetonitrile:water (60:40 (v/v)). Flutamide was used as internal standard (IS). The assay was linear in the concentration range of 10-1000 ng/ml when 0.5 ml aliquots of plasma were extracted. Within-day and between-day precision expressed by relative standard deviation is less than 4% and inaccuracy does not exceed 3%. The assay was used to analyze samples collected during human clinical studies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15137994     DOI: 10.1016/j.jpba.2004.02.005

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion.

Authors:  Faiyaz Shakeel; Sanjula Baboota; Alka Ahuja; Javed Ali; Sheikh Shafiq
Journal:  J Nanobiotechnology       Date:  2008-07-09       Impact factor: 10.435

2.  Celecoxib-Loaded Solid Lipid Nanoparticles for Colon Delivery: Formulation Optimization and In Vitro Assessment of Anti-Cancer Activity.

Authors:  Hamdan N Alajami; Ehab A Fouad; Abdelkader E Ashour; Ashok Kumar; Alaa Eldeen B Yassin
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.